Statement of Additional Information Supplement October 14, 2026
    

 

 

 

Gilead Fund    
ETAGX Class A Shares ETCGX Class C Shares
ETGLX Class N Shares ETILX Class I Shares
       
Healthcare & Life Sciences Fund    
ETAHX Class A Shares ETCHX Class C Shares
ETNHX Class N Shares ETIHX Class I Shares
       
Balanced Fund    
ETAMX Class A Shares ETCMX Class C Shares
ETNMX Class N Shares ETIMX Class I Shares
       
Dividend Growth Fund    
ETADX Class A Shares ETCDX Class C Shares
ETNDX Class N Shares ETIDC Class I Shares
       
Limited-Term Bond Fund    
ETADX Class A Shares ETCDX Class C Shares
ETNDX Class N Shares ETIDX Class I Shares
       
Exponential Technologies Fund    
ETAEX Class A Shares ETCEX Class C Shares
ETNEX Class N Shares ETIEX Class I Shares
       
Core Bond Fund    
ETARX Class A Shares ETCRX Class C Shares
ETNRX Class N Shares ETIRX Class I Shares
       
Large Cap Focus Fund    
ETLAX Class A Shares ETLCX Class C Shares
ETLNX Class N Shares ETLIX Class I Shares
       
       
(each a “Fund” and collectively, the “Funds”)

 

 

 

This information supplements certain information contained in the Statement of Additional Information (“SAI”) for the Funds, dated November 1, 2025, as supplemented, and should be read in conjunction with such SAI.

 

The information under the section of the Fund’s SAI entitled “Disclosure of Portfolio Holdings” is replaced in its entirety with the following information:

 

EVENTIDE1

 

 

 

Statement of
Additional Information Supplement

October 14, 2026

 

 

 

The Board has adopted policies and procedures for the public and nonpublic disclosure of the Funds’ portfolio securities.

 

As a general matter, no information concerning the portfolio holdings of a Fund may be disclosed to any unaffiliated third party, except (1) to service providers that require such information in the course of performing their duties (for example, the Fund’s custodian, administrator, investment adviser, sub-investment adviser, independent public accountants, attorneys, officers, and trustees), subject to a duty of confidentiality including duties not to trade on non-public information, and 2) select portfolio holdings information may be provided to shareholders of a Fund when the Fund has a legitimate business purpose for doing so, subject to approval by the Trust’s Chief Compliance Officer and the execution of a confidentiality agreement.

 

However, information about portfolio holdings may be made available to third parties: (1) by providing a copy of a Fund’s latest annual or semi-annual report or the Fund’s latest Form N-CSR; (2) on a Fund’s website through the Fund’s public disclosure of its portfolio holdings on a quarterly or monthly basis as applicable; (3) in marketing materials that reproduce the information from, and reference, the latest annual or semi-annual report or the Funds’ latest Form N-CSR; (4) in marketing materials provided by the Funds or on the Funds’ website; and (5) when the Funds have a legitimate business purpose for doing so and the recipients are subject to confidentiality. Examples of instances in which selective disclosure of a Fund’s portfolio securities may be appropriate include disclosure for due diligence purposes to an investment adviser that is in merger or acquisition talks with the Fund’s current adviser, disclosure to a newly hired investment adviser or sub-adviser prior to commencing its duties, disclosure to a performance reporting bureau or to a rating agency for use in developing a rating.

 

Neither the Funds nor the Adviser may enter into any arrangement providing for the disclosure of non-public portfolio holdings information for the receipt of compensation.

 

You should read this Supplement in conjunction with the Prospectus, Summary Prospectus and the Statement of Additional Information for the Funds each dated November 1, 2025, as supplemented, which provide information that you should know about the Funds before investing. These documents are available upon request and without charge by calling the Funds toll-free at 1-877-771-3836 or by writing to 225 Pictoria Drive, Suite 450, Cincinnati, OH 45246.

 

Please retain this Supplement for future reference.

 

EVENTIDE2